×
0 0 -0.0107526881720429 0 0 -0.017921146953405 -0.00358422939068093 -0.014336917562724
Stockreport

Applied Genetic Technologies: Biogen's Deal Termination Was Premature [Seeking Alpha]

Applied Genetic Technologies Corp (AGTC)  More Company Research Source: Seeking Alpha
Last applied genetic technologies corp earnings: 2/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.agtc.com/investor-relations
PDF On December 12, 2018 Applied Genetic Technology ( AGTC ) announced results from its phase 1/2 trial treating patients with X-linked retinoschisis (XLRS). After the results were announced, it was noted that Biogen ( BIIB ) would end its partnership with the company due to lack of clinical activity in this study. Even though this program didn't succeed against this disease, AGTC does have other candidates in the clinic. I believe that the three readouts due in 2019 may provide a possible turnaround situation. Partnership Fallout The phase 1/2 XLRS trial was an open-label dose escalation study designed to look at the safety and efficacy of intravitreal administration of the AAV-based gene therapy to treat patients with XLRS. XLRS is caused by genetic mutations of the RS1 gene. It is a rare genetic condition that affects boys and men. The main symptom of this disease is progressive vision loss. In other words, reduced vision which can't be helped by glasses. The [Read more]

IMPACT SNAPSHOT EVENT TIME: AGTC
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AGTC alerts
from News Quantified
Opt-in for
AGTC alerts

from News Quantified
Opt-in for
AGTC alerts

from News Quantified